NEW YORK (GenomeWeb) – Quest Diagnostics this week announced that its board of directors approved a quarterly cash dividend of $.40 per share, payable on Oct. 19 to shareholders of record on Oct. 4.

Rubicon Genomics this week reported that its product sales rose 43 percent in the first half of 2016 from H1 2015. The company also announced the start of an early-access program for its new ThruPlex Tag-seq kits, which enable detection of low-frequency alleles with greater confidence. The program is available to both academic and commercial researchers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.